About AngioScore
AngioScore is a company based in Fremont (United States) founded in 2003 was acquired by Spectranetics GSM in May 2014.. AngioScore has raised $87 million across 4 funding rounds from investors including Spectranetics GSM, Saints Capital and Psilos Group. AngioScore operates in a competitive market with competitors including Contego Medical, Echopoint Medical, Limflow, Vascular Solutions and ev3 Endovascular, among others.
- Headquarter Fremont, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Angioscore Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$87 M (USD)
in 4 rounds
-
Latest Funding Round
$12 M (USD), Series E
Apr 26, 2011
-
Investors
Spectranetics GSM
& 6 more
-
Employee Count
Employee Count
-
Acquired by
Spectranetics GSM
(May 27, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of AngioScore
AngioScore has successfully raised a total of $87M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $12 million completed in April 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series E — $12.0M
-
First Round
First Round
(23 Aug 2004)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2011 | Amount | Series E - AngioScore | Valuation | Saints Capital | |
| Oct, 2007 | Amount | Series E - AngioScore | Valuation |
investors |
|
| Apr, 2006 | Amount | Series D - AngioScore | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AngioScore
AngioScore has secured backing from 7 investors, including venture fund investors. Prominent investors backing the company include Spectranetics GSM, Saints Capital and Psilos Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Direct secondary investments are made in private company shares.
|
Founded Year | Domain | Location | |
|
Growth-stage investments focused on US tech and life sciences.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AngioScore
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AngioScore
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Angioscore Comparisons
Competitors of AngioScore
AngioScore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Contego Medical, Echopoint Medical, Limflow, Vascular Solutions and ev3 Endovascular, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature
|
|
| domain | founded_year | HQ Location |
Smart devices for monitoring coronary artery disease are developed.
|
|
| domain | founded_year | HQ Location |
Developer a system for venous arterialization of the lower limbs
|
|
| domain | founded_year | HQ Location |
Products for vascular diagnostics and interventional procedures are developed.
|
|
| domain | founded_year | HQ Location |
Surgical products for treatment of Peripheral vascular & Neurovascular diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about AngioScore
When was AngioScore founded?
AngioScore was founded in 2003 and raised its 1st funding round 1 year after it was founded.
Where is AngioScore located?
AngioScore is headquartered in Fremont, United States. It is registered at Fremont, California, United States.
Is AngioScore a funded company?
AngioScore is a funded company, having raised a total of $87M across 4 funding rounds to date. The company's 1st funding round was a Series D of $30M, raised on Aug 23, 2004.
What does AngioScore do?
AngioScore was founded in 2003 as an Israeli-American startup focused on medical devices for cardiovascular treatments. The AngioSculpt Scoring Balloon Catheter was created to address coronary and peripheral artery diseases through angioplasty procedures. Regulatory approvals, including CE marking and FDA clearance, were secured for these products. The company was acquired by Spectranetics in June 2014, with operations centered in Fremont, United States.
Who are the top competitors of AngioScore?
AngioScore's top competitors include Contego Medical, Limflow and Shape Memory Medical.
Who are AngioScore's investors?
AngioScore has 7 investors. Key investors include Spectranetics GSM, Saints Capital, Psilos Group, Telegraph Hill Partners, and QuestMark Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.